Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt ® Eye Drops, 20 mg/mL + 5 mg/mL
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzotimol eye drops, 20 mg/mL + 5 mg/mL; Drug: Cosopt eye drops, 20 mg/mL + 5 mg/mL Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt ® Eye Drops, 20 mg/ml
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzol 20 mg/ml; Drug: Trusopt 20 mg/ml Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt ® Eye Drops, 20 mg/mL + 5 mg/mL
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzotimol eye drops, 20 mg/mL + 5 mg/mL; Drug: Cosopt eye drops, 20 mg/mL + 5 mg/mL Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Healthy Little Eyes
Conditions: Hypoxic-Ischemic Encephalopathy; Neonatal Encephalopathy; Encephalopathy Interventions: Device: Visual Evoked Potential (VEP); Device: Electroretinogram (ERG) Sponsors: University of Wisconsin, Madison; Meriter Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt ® Eye Drops, 20 mg/ml
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzol 20 mg/ml; Drug: Trusopt 20 mg/ml Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt ® Eye Drops, 20 mg/mL + 5 mg/mL
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzotimol eye drops, 20 mg/mL + 5 mg/mL; Drug: Cosopt eye drops, 20 mg/mL + 5 mg/mL Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Healthy Little Eyes
Conditions: Hypoxic-Ischemic Encephalopathy; Neonatal Encephalopathy; Encephalopathy Interventions: Device: Visual Evoked Potential (VEP); Device: Electroretinogram (ERG) Sponsors: University of Wisconsin, Madison; Meriter Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt ® Eye Drops, 20 mg/ml
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzol 20 mg/ml; Drug: Trusopt 20 mg/ml Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt ® Eye Drops, 20 mg/mL + 5 mg/mL
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzotimol eye drops, 20 mg/mL + 5 mg/mL; Drug: Cosopt eye drops, 20 mg/mL + 5 mg/mL Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Healthy Little Eyes
Conditions: Hypoxic-Ischemic Encephalopathy; Neonatal Encephalopathy; Encephalopathy Interventions: Device: Visual Evoked Potential (VEP); Device: Electroretinogram (ERG) Sponsors: University of Wisconsin, Madison; Meriter Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt ® Eye Drops, 20 mg/ml
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzol 20 mg/ml; Drug: Trusopt 20 mg/ml Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt ® Eye Drops, 20 mg/mL + 5 mg/mL
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzotimol eye drops, 20 mg/mL + 5 mg/mL; Drug: Cosopt eye drops, 20 mg/mL + 5 mg/mL Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Healthy Little Eyes
Conditions: Hypoxic-Ischemic Encephalopathy; Neonatal Encephalopathy; Encephalopathy Interventions: Device: Visual Evoked Potential (VEP); Device: Electroretinogram (ERG) Sponsors: University of Wisconsin, Madison; Meriter Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL Versus Cosopt ® Eye Drops, 20 mg/mL + 5 mg/mL
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzotimol eye drops, 20 mg/mL + 5 mg/mL; Drug: Cosopt eye drops, 20 mg/mL + 5 mg/mL Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials
Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt ® Eye Drops, 20 mg/ml
Condition: Primary Open Angle Glaucoma of Both Eyes Interventions: Drug: Dorzol 20 mg/ml; Drug: Trusopt 20 mg/ml Sponsor: Jadran Galenski laboratorij d.d. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials